BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.

BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives take hold.

BSX rallies 40.5% in a year, fueled by WATCHMAN growth, MedSurg gains, acquisitions and global expansion efforts.

AXON lifts 2025 EBITDA outlook as strong TASER and body cam sales drive margin gains despite rising costs.

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

AYI surges on strong Q3 results as acquisitions and tech-driven segments power 23% EPS growth and margin gains.

AYI surges on strong Q3 results as acquisitions and tech-driven segments power 23% EPS growth and margin gains.

PPC hit a 12% EBITDA margin in the first quarter of 2025, boosted by U.S. gains and strong pricing across key segments.

PPC hit a 12% EBITDA margin in the first quarter of 2025, boosted by U.S. gains and strong pricing across key segments.

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a...